PR - Resizing - Kaplan Fox Tagline Logo Color.jpg
CHPT Investor Alert: Kaplan Fox & Kilsheimer LLP Notifies ChargePoint Investors of a Class Action Lawsuit and Upcoming Deadline
December 07, 2023 08:00 ET | Kaplan Fox & Kilsheimer LLP
Kaplan Fox reminds investors that a complaint has been filed on behalf of investors that purchased or otherwise acquired ChargePoint Holdings, Inc.
PR - Resizing - Kaplan Fox Tagline Logo Color.jpg
EGRX Investor Alert: Kaplan Fox & Kilsheimer LLP Investigates Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX)
December 07, 2023 08:00 ET | Kaplan Fox & Kilsheimer LLP
Kaplan Fox & Kilsheimer LLP is investigating potential claims on behalf of investors who purchased securities of Eagle Pharmaceuticals, Inc.
PR - Resizing - Kaplan Fox Tagline Logo Color.jpg
SLRN Investor Alert: Kaplan Fox & Kilsheimer LLP Investigates Acelyrin, Inc. (Nasdaq: SLRN)
December 07, 2023 08:00 ET | Kaplan Fox & Kilsheimer LLP
Kaplan Fox & Kilsheimer LLP is investigating potential claims on behalf of investors who purchased Acelyrin, Inc.
factMR-logo.png
Angiography Catheter Market Size Worth US$ 3.05 Billion by 2034 at CAGR of 6.9% : Fact.MR Report
December 07, 2023 08:00 ET | FACT.MR
Rockville , Dec. 07, 2023 (GLOBE NEWSWIRE) -- The global angiography catheter market size is projected to expand at 6.9% CAGR and reach a valuation of US$ 3.05 billion by 2034-end, driven by a...
multitude_logo_01.png
Multitude Group financial calendar for 2024
December 07, 2023 08:00 ET | Multitude SE
Multitude Group financial calendar for 2024 Helsinki, 7 December 2023 – Multitude SE (ISIN: FI4000106299, WKN: A1W9NS) (“Multitude” or the “Group”) announces the following publication dates of the...
Microbot Logo.jpg
Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study
December 07, 2023 08:00 ET | Microbot Medical Inc.
The final histopathology and lab report supplements previous positive Company findings. The results of the study will support the Company’s IDE submission to the FDA to commence its human...
png.png
MedBright AI Announces Beta Customer for MedMatrix, the AI-Driven Data and Analytics Platform
December 07, 2023 08:00 ET | MedBright AI Investments Inc.
MedBright AI Announces Beta Customer for MedMatrix, the AI-Driven Data and Analytics Platform
TechFlow_logo_AA.png
TechFlow Secures 7-Year $2.1 Billion TSA Contract for Explosives Detection System Upkeep at Over 300 Facilities Spanning the U.S. and its Territories
December 07, 2023 08:00 ET | TechFlow, Inc.
TechFlow Secures 7-Year $2.1 Billion TSA Contract for Explosives Detection System Upkeep at Over 300 Facilities Spanning the U.S. and its Territories
Phio.jpg
Phio Pharmaceuticals Announces Exercise of Warrants for $2.8 Million Gross Proceeds
December 07, 2023 08:00 ET | Phio Pharmaceuticals Corp.
MARLBOROUGH, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is...
Vittoria Bio Logo_RGB.png
Vittoria Biotherapeutics Announces FDA Clearance of IND Application for VIPER-101 to Treat T-Cell Lymphoma
December 07, 2023 08:00 ET | Vittoria Biotherapeutics
VIPER-101 is an autologous, CD5 knock-out CAR-T therapy for the treatment of T-cell lymphoma Initiating first-in-human Phase 1 trial in H1 of 2024 PHILADELPHIA, Dec. 07, 2023 (GLOBE NEWSWIRE) --...